Purpose: Recent studies have illustrated that the peritumoral regions of medical images have value for clinical diagnosis. However, the existing approaches using peritumoral regions mainly focus on the diagnostic capability of the single region and ignore the advantages of effectively fusing the intratumoral and peritumoral regions. In addition, these methods need accurate segmentation masks in the testing stage, which are tedious and inconvenient in clinical applications. To address these issues, we construct a deep convolutional neural network that can adaptively fuse the information of multiple tumoral-regions (FMRNet) for breast tumor classification using ultrasound (US) images without segmentation masks in the testing stage.
Methods: To sufficiently excavate the potential relationship, we design a fused network and two independent modules to extract and fuse features of multiple regions simultaneously. First, we introduce two enhanced combined-tumoral (EC) region modules, aiming to enhance the combined-tumoral features gradually. Then, we further design a three-branch module for extracting and fusing the features of intratumoral, peritumoral, and combined-tumoral regions, denoted as the intratumoral, peritumoral, and combined-tumoral module. Especially, we design a novel fusion module by introducing a channel attention module to adaptively fuse the features of three regions. The model is evaluated on two public datasets including UDIAT and BUSI with breast tumor ultrasound images. Two independent groups of experiments are performed on two respective datasets using the fivefold stratified cross-validation strategy. Finally, we conduct ablation experiments on two datasets, in which BUSI is used as the training set and UDIAT is used as the testing set.
Results: We conduct detailed ablation experiments about the proposed two modules and comparative experiments with other existing representative methods. The experimental results show that the proposed method yields state-of-the-art performance on both two datasets. Especially, in the UDIAT dataset, the proposed FMRNet achieves a high accuracy of 0.945 and a specificity of 0.945, respectively. Moreover, the precision (PRE = 0.909) even dramatically improves by 21.6% on the BUSI dataset compared with the existing method of the best result.
Conclusion: The proposed FMRNet shows good performance in breast tumor classification with US images, and proves its capability of exploiting and fusing the information of multiple tumoral-regions. Furthermore, the FMRNet has potential value in classifying other types of cancers using multiple tumoral-regions of other kinds of medical images.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mp.15341 | DOI Listing |
Heliyon
January 2025
BRITElab, Harry Perkins Institute of Medical Research, QEII Medical Centre Nedlands and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Breast-conserving surgery accompanied by adjuvant radiotherapy is the standard of care for patients with early-stage breast cancer. However, re-excision is reported in 20-30 % of cases, largely because of close or involved tumor margins in the specimen. Several intraoperative tumor margin assessment techniques have been proposed to overcome this issue, however, none have been widely adopted.
View Article and Find Full Text PDFVet Res Forum
November 2024
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Docetaxel (DTX) is widely utilized in breast cancer treatment. However, cancer cell resistance has limited its anti-tumor efficacy. Some molecules called microRNAs (miRNAs), acting like fine-tuned switches, can influence how breast cancer develops and spreads.
View Article and Find Full Text PDFOncol Lett
March 2025
Department of Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong 261042, P.R. China.
A hyalinizing trabecular tumor (HTT), characterized by a trabecular growth pattern and notable hyalinization within the trabeculae, occurs at a rate of ~1%. As patients with HTT may be asymptomatic, accurate diagnosis is a challenge. Due to its resemblance to other tumors, such as papillary thyroid carcinoma and medullary thyroid carcinoma, a precise diagnosis necessitates both pathological and molecular examinations.
View Article and Find Full Text PDFInt J Surg
December 2024
Department of Oncology and Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Background: Biological evidence has revealed antitumor effect of vitamin D, but whether it could predict the response to neoadjuvant chemotherapy (NAC) in breast cancer (BC) patients remains inconclusive. The aim was to investigate the association between pretreatment vitamin D level and response to NAC and subsequent survival outcomes in BC patients.
Materials And Methods: The authors systematically searched the Medline, Embase, Cochrane Library, and Web of Science databases and clinical trial registries to identify relevant articles from inception to 8 October 2024.
Int J Surg
December 2024
Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine.
Introduction: Nipple-sparing mastectomy (NSM) aims to improve patient satisfaction by preserving the nipple-areola complex (NAC) while ensuring oncologic safety. Different surgical incisions, such as inframammary fold (IMF) and periareolar/radial incisions, are used in NSM; however, their impact on NAC sensory loss remains unclear. In this study, the authors aimed to assess NAC sensation after NSM and compare the results of different incisional approaches, specifically IMF versus periareolar/radial.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!